DGKB and Autoimmunity: As DAG has numerous downstream targets, one would predict that potential therapies to modulate DGK function would be most useful in areas where broad manipulation of TCR signaling is desirable, such as in suppressing autoimmunity or enhancing immune responses to cancer.